Dr. Bhandari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
616 S Washington St
Bastrop, LA 71220Phone+1 318-283-2177Fax+1 318-283-2251
Education & Training
NYU Grossman Long Island School of MedicineFellowship, Gastroenterology, 1992 - 1995
Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Residency, Internal Medicine, 1989 - 1991
University of Ottawa Faculty of MedicineClass of 1987
Certifications & Licensure
SC State Medical License 2022 - 2025
LA State Medical License 1995 - 2024- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- 556 citationsABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCVPeter Ferenci, David E. Bernstein, Jacob Lalezari, Daniel E. Cohen, Yan Luo
The New England Journal of Medicine. 2014-05-21 - 143 citationsA phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer
Gastrointestinal Endoscopy. 2018-09-01 - 122 citationsEfficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.William J. Sandborn, Marc Ferrante, Bal R. Bhandari, Elina Berliba, Brian G. Feagan
Gastroenterology. 2020-02-01
Press Mentions
Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB174 for Hepatic Encephalopathy at the Digital International Liver Congress™ (EASL)August 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
